	US 11,992,511 B2
	Lactobacillus paracasei strain and use thereof
Gwang Pyo Ko, Seoul (KR); Woonki Kim, Ulsan (KR); You-Jin Jang, Seoul (KR); Boram Seo, Gyeonggi-do (KR); June-Chul Lee, Gyeonggi-do (KR); Tae-Wook Nam, Gyeonggi-do (KR); Insu Kim, Gyeonggi-do (KR); and Jin-Woo Lee, Gyeonggi-do (KR)
Assigned to KoBioLabs, Inc., Seoul (KR)
Filed by KoBioLabs, Inc., Seoul (KR)
Filed on Feb. 16, 2022, as Appl. No. 17/673,460.
Application 17/673,460 is a continuation of application No. 17/093,556, filed on Nov. 9, 2020, granted, now 11,291,698.
Application 17/093,556 is a continuation of application No. PCT/KR2019/005553, filed on May 9, 2019.
Claims priority of application No. 10-2018-0053279 (KR), filed on May 9, 2018.
Prior Publication US 2022/0175857 A1, Jun. 9, 2022
Int. Cl. A61K 35/747 (2015.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A61P 1/00 (2006.01); A61P 37/08 (2006.01); C12N 1/20 (2006.01); A61K 35/00 (2006.01); C12R 1/225 (2006.01)

CPC A61K 35/747 (2013.01) [A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61P 1/00 (2018.01); A61P 37/08 (2018.01); C12N 1/20 (2013.01); C12N 1/205 (2021.05); A23V 2002/00 (2013.01); A23V 2400/165 (2023.08); A61K 2035/115 (2013.01); C12R 2001/225 (2021.05)]

17 Claims

1. A composition in a dry dosage form of capsule, tablet, or powder, comprising: at least one lyophilized strain of Lactobacillus paracasei selected from Lactobacillus paracasei KBL384 with Accession No. KCTC13510BP, Lactobacillus paracasei KBL385 with Accession No. KCTC13511BP, or lyophilized cultures of said strain.